Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ralph Lauren Corp RL

Ralph Lauren Corporation is engaged in the design, marketing, and distribution of luxury lifestyle products, including apparel, footwear & accessories, home, fragrances, and hospitality. Its segments include North America, Europe, and Asia. Its brands include Ralph Lauren, Ralph Lauren Collection, Ralph Lauren Purple Label, Double RL, Polo Ralph Lauren, Lauren Ralph Lauren, Polo Ralph Lauren... see more

Recent & Breaking News (NYSE:RL)

Sarvint Technologies Files Complaints for Patent Infringement for Wearable Technology

PR Newswire January 12, 2015

MELA Sciences CEO Michael R. Stewart to Present at the Eighth Annual OneMedForum January 13 at 2 p.m.

GlobeNewswire January 8, 2015

AMP has Strong Presence at FDA Workshop on LDTs, Delivers Message of Optimizing Patient Care through Molecular Diagnostics

Business Wire January 8, 2015

Trevi Therapeutics Closes $15 Million Debt Facility Provided by Solar Capital and Square 1 Bank

Business Wire January 8, 2015

CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related Kaposi's Sarcoma (KS)

PR Newswire January 8, 2015

Xeris Pharmaceuticals Completes $17.9M Series B Round and Appoints Phillip Johnson as Chief Financial Officer

GlobeNewswire January 7, 2015

Cipher Pharmaceuticals acquires Canadian commercialization rights to novel antibacterial compound Ozenoxacin

Canada NewsWire January 7, 2015

Dr. Patrick Sullivan Published in ASPS' Plastic and Reconstructive Surgery Journal

Marketwired January 7, 2015

RestorGenex to Present at Biotech Showcase 2015

Business Wire January 7, 2015

United Medical Credit Will be Attending the American Academy of Cosmetic Surgery (AACS) Convention in January with Special Guest Cheryl Whitman

PR Newswire January 6, 2015

Ultragenyx Initiates New Development Program Studying KRN23 for the Treatment of Tumor-Induced Osteomalacia

GlobeNewswire January 6, 2015

cCAM Biotherapeutics Receives FDA Approval to Initiate Phase 1 Trial for CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy

Business Wire January 6, 2015

Cohera Medical, Inc.® Receives PMA Approvable Letter from U.S. FDA for TissuGlu® Surgical Adhesive

PR Newswire January 6, 2015

Two major milestones for ground-breaking melanoma immunotherapies bring a hopeful beginning for 2015

Canada NewsWire January 6, 2015

LEO Pharma Announces US Regulatory Submission of the First Aerosol Foam for Psoriasis

Canada NewsWire January 6, 2015

Kamedis, a Leading Israeli Biotechnology Firm, is to Enter the Chinese Skin Care Market in 2015 with Clinically Tested, Traditionally Based Products

PR Newswire January 5, 2015

NovaBay Rebrands Its i-Lid Cleanser as Avenova

Business Wire January 5, 2015

Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome

PR Newswire January 5, 2015

Wound Dressings Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

PR Newswire December 31, 2014

United Therapeutics Announces Signing Of Agreement For New Remodulin Delivery System

PR Newswire December 31, 2014